Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
Top Cited Papers
- 1 November 2006
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (11), 3839-3846
- https://doi.org/10.1128/aac.00684-06
Abstract
Fungal pathogens form biofilms that are highly recalcitrant to antimicrobial therapy. The expression of multidrug resistance pumps in young biofilms has been linked to increased resistance to azoles, but this mechanism does not seem to underlie the resistance of mature biofilms that is a model of in vivo infection. The mechanism of drug resistance of mature biofilms remains largely unknown. We report that biofilms formed by the major human pathogen Candida albicans exhibited a strikingly biphasic killing pattern in response to two microbicidal agents, amphotericin B, a polyene antifungal, and chlorhexidine, an antiseptic, indicating that a subpopulation of highly tolerant cells, termed persisters, existed. The extent of killing with a combination of amphotericin B and chlorhexidine was similar to that observed with individually added antimicrobials. Thus, surviving persisters form a multidrug-tolerant subpopulation. Interestingly, surviving C. albicans persisters were detected only in biofilms and not in exponentially growing or stationary-phase planktonic populations. Reinoculation of cells that survived killing of the biofilm by amphotericin B produced a new biofilm with a new subpopulation of persisters. This suggests that C. albicans persisters are not mutants but phenotypic variants of the wild type. Using a stain for dead cells, rare dark cells were visible in a biofilm after amphotericin B treatment, and a bright and a dim population were physically sorted from this biofilm. Only the dim cells produced colonies, showing that this method allows the isolation of yeast persisters. Given that persisters formed only in biofilms, mutants defective in biofilm formation were examined for tolerance of amphotericin B. All of the known mutants affected in biofilm formation were able to produce normal levels of persisters. This finding indicates that attachment rather than formation of a complex biofilm architecture initiates persister formation. Bacteria produce multidrug-tolerant persister cells in both planktonic and biofilm populations, and it appears that yeasts and bacteria have evolved analogous strategies that assign the function of survival to a small part of the population. In bacteria, persisters are dormant cells. It remains to be seen whether attachment initiates dormancy that leads to the formation of fungal persisters. This study suggests that persisters may be largely responsible for the multidrug tolerance of fungal biofilms.Keywords
This publication has 50 references indexed in Scilit:
- Increased Persistence in Escherichia coli Caused by Controlled Expression of Toxins or Other Unrelated ProteinsJournal of Bacteriology, 2006
- La caspofungine : du mécanisme d'action aux applications thérapeutiquesLa Revue de Médecine Interne, 2006
- Chlorhexidine GluconateAustralian Endodontic Journal, 2005
- In Vitro Method To Study Antifungal Perfusion in Candida BiofilmsJournal of Clinical Microbiology, 2005
- Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coliJournal of Bacteriology, 2004
- Candida biofilm resistanceDrug Resistance Updates, 2004
- Efficacy of antiseptics and disinfectants on clinical and environmental yeast isolates in planktonic and biofilm conditionsJournal of Medical Microbiology, 2004
- Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicans Is Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1 , CDR2 , CaMDR1 , and FLU1 GenesAntimicrobial Agents and Chemotherapy, 2003
- Candida biofilmsCurrent Opinion in Microbiology, 2002
- Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans BiofilmsAntimicrobial Agents and Chemotherapy, 2001